Abstract
For over three decades, a mainstay and goal of clinical oncology has been the development of therapies promoting the effective elimination of cancer cells by apoptosis. This programmed cell death process is mediated by several signalling pathways (referred to as intrinsic and extrinsic) triggered by multiple factors, including cellular stress, DNA damage and immune surveillance. The interaction of apoptosis pathways with other signalling mechanisms can also affect cell death. The clinical translation of effective pro-apoptotic agents involves drug discovery studies (addressing the bioavailability, stability, tumour penetration, toxicity profile in non-malignant tissues, drug interactions and off-target effects) as well as an understanding of tumour biology (including heterogeneity and evolution of resistant clones). While tumour cell death can result in response to therapy, the selection, growth and dissemination of resistant cells can ultimately be fatal. In this Review, we present the main apoptosis pathways and other signalling pathways that interact with them, and discuss actionable molecular targets, therapeutic agents in clinical translation and known mechanisms of resistance to these agents.
Keywords
ApoptosisProgrammed cell deathMedicineCancer researchDNA damageCancerCancer cellTranslation (biology)Immune systemBioinformaticsImmunologyBiologyDNAGeneticsInternal medicine
MeSH Terms
ApoptosisDNA DamageDrug ResistanceNeoplasmHumansMolecular Targeted TherapyNeoplasmsSignal Transduction
Affiliated Institutions
Related Publications
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
The tumour suppressor p53 is required to induce programmed cell death (apoptosis) by DNA-damaging agents. As p53 is a transcriptional activator that mediates gene induction afte...
Mitochondria as multifaceted regulators of cell death
Through their many and varied metabolic functions, mitochondria power life. Paradoxically, mitochondria also have a central role in apoptotic cell death. Upon induction of mitoc...
Inhibition of Ced-3/ICE-related Proteases Does Not Prevent Cell Death Induced by Oncogenes, DNA Damage, or the Bcl-2 Homologue Bak
There is increasing evidence for a central role in mammalian apoptosis of the interleukin-1β– converting enzyme (ICE) family of cysteine proteases, homologues of the product of ...
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Apoptosis is a genetically encoded programme of cell death that can be activated under physiological conditions and may be an important safeguard against tumour development. Reg...
Dysregulation of Apoptosis in Cancer
ABSTRACT: Each day, approximately 50 to 70 billion cells perish in the average adult because of programmed cell death (PCD). Cell death in self-renewing tissues, such as the ski...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 17
- Issue
- 7
- Pages
- 395-417
- Citations
- 2396
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2396
OpenAlex
24
Influential
Cite This
Benedito A. Carneiro,
Wafik S. El‐Deiry
(2020).
Targeting apoptosis in cancer therapy.
Nature Reviews Clinical Oncology
, 17
(7)
, 395-417.
https://doi.org/10.1038/s41571-020-0341-y
Identifiers
- DOI
- 10.1038/s41571-020-0341-y
- PMID
- 32203277
- PMCID
- PMC8211386